Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-039162
Filing Date
2017-06-12
Accepted
2017-06-12 16:25:12
Documents
2
Period of Report
2017-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2175
2 POA DOCUMENT poa.txt EX-24.3_730537 3987
  Complete submission text file 0001209191-17-039162.txt   7517
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address EXPERIMENTAL STATION ROUTE 141 AND HENRY CLAY RD WILMINGTON DE 19880
Business Address
Andrews Patricia S (Reporting) CIK: 0001445710 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36177 | Film No.: 17906564